CARBOCAINE 1% 10 MG
MEPIVACAINE HYDROCHLORIDE : 10 MG · DIN 02241999 · PFIZER CANADA ULC
Health Canada status: MARKETED
What is CARBOCAINE 1%?
CARBOCAINE 1% 10 MG contains MEPIVACAINE HYDROCHLORIDE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02241999, held by PFIZER CANADA ULC, supplied as SOLUTION for EPIDURAL ; INTRACAUDAL administration. Health Canada currently lists it as marketed, status dated 02-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CARBOCAINE 1% used for?
CARBOCAINE is indicated for production of local or regional analgesia and/or anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks. Specific concentrations and presentations of CARBOCAINE are recommended for each type of block indicated to produce local or regional anesthesia or analgesia.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is CARBOCAINE 1% called?
The same molecule, MEPIVACAINE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Mepidor vet. | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02241999 |
|---|---|
| Brand name | CARBOCAINE 1% |
| Generic / active ingredient | MEPIVACAINE HYDROCHLORIDE : 10 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 10 MG |
| Dosage form | SOLUTION |
| Route of administration | EPIDURAL ; INTRACAUDAL |
| Schedule | Ethical |
| ATC code | N01BB03 MEPIVACAINE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 02-Aug-2017 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02241999 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2241999 |
| Brand name | CARBOCAINE 1% |
| Active ingredient / INN | MEPIVACAINE HYDROCHLORIDE : 10 MG |
| ATC code | N01BB03 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N01 |
| Health Canada schedule | Ethical |
| Biosimilar biologic | No |
| Market authorization holder | PFIZER CANADA ULC |
How is it stored and handled?
null
How is it supplied?
null
Which pack is which?
| Strength on the label | 10 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | EPIDURAL ; INTRACAUDAL |
| Packaging as described in the monograph | null |
| Storage | null |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code N01BB03 MEPIVACAINE. 7 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| 3% POLOCAINE DENTAL | 30 MG | LIQUID | DENTSPLY CANADA LIMITED | MARKETED | DIN 02330733 |
| CARBOCAINE 1% | 10 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02242000 |
| CARBOCAINE 2% | 20 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02242001 |
| CARBOCAINE 3% | 30 MG | SOLUTION | SEPTODONT | MARKETED | DIN 02474174 |
| ISOCAINE HCL INJ 3% | 30 MG | SOLUTION | NOVOCOL PHARMACEUTICAL OF CANADA INC | MARKETED | DIN 00364304 |
| SCANDONEST 3% PLAIN INJ | 30 MG | SOLUTION | SEPTODONT | MARKETED | DIN 00479934 |
| CARBOCAINE 3% | 30 MG | SOLUTION | KODAK CANADA INC. | CANCELLED POST MARKET | DIN 01985078 |
| CARBOCAINE 3% | 30 MG | SOLUTION | CARESTREAM HEALTH CANADA COMPANY | CANCELLED POST MARKET | DIN 02271796 |
| CARBOCAINE INJ LIQ 10MG/ML | 10 MG | LIQUID | STERLING WINTHROP INC. | CANCELLED POST MARKET | DIN 01959891 |
| CARBOCAINE INJ LIQ 20MG/ML | 20 MG | LIQUID | STERLING WINTHROP INC. | CANCELLED POST MARKET | DIN 01959913 |
How much does MEPIVACAINE cost around the world?
MEPIVACAINE is listed on 5 national price registers Nexara tracks, across 11 pack listings published on 5 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Austria | KVP (Kassenverkaufspreis) | 3 | 3 | 03 Sep 2026 |
| Greece | producer price (ex-factory) | 3 | 3 | 03 Sep 2026 |
| Morocco | PPV (public price) | 3 | 3 | 05 Sep 2026 |
| Iceland | max wholesale | 1 | 1 | 02 Sep 2026 |
| South Africa | single exit price | 1 | 1 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.